BioSpace News Archive

HalioDx Banks $22.3M Series B Funding Round

This fundraising is intended to accelerate the development of Immunoscore for colon cancer and selected additional cancer types and set up commercial activities in the U.S.

January 17, 2018
·
8 min read
Drug Development

MiMedx Announces the Enrollment of the First Patients in the Phase III Clinical Trial of AmnioFix Injectable for Achilles Tendonitis

The design of the Phase 3 Achilles Tendonitis study will include approximately 158 patients.

January 17, 2018
·
5 min read
BioCapital

Intrexon Corp. Prices Public Offering of Common Stock

Intrexon announced today that it has priced its previously announced underwritten public offering of common stock consisting of 6,000,000 shares at a public offering price of $12.50 per share.

January 17, 2018
·
3 min read
Drug Development

VBI Vaccines Announces Dosing of First GBM Patient in Phase I/IIa Clinical Study of VBI-1901

The multi-center, open-label, two-part study will enroll up to 28 patients and is designed to evaluate safety, tolerability, and the optimal therapeutic dose level of VBI-1901.

January 17, 2018
·
6 min read
Drug Development

BeyondSpring to Present Data From Phase II Portion of Study 105 Phase II/III Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Company to host conference call on Jan. 29 at 8:30 A.M. ET to review data.

January 17, 2018
·
5 min read
Genetown

Genocea Biosciences Announces Pricing of $55M Concurrent Public Offerings

The Class A warrants sold in each of the offerings will have the same terms.

January 17, 2018
·
5 min read
Business

OraSure Technologies Earnings Conference Call Invitation

The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website.

January 17, 2018
·
1 min read
BioMidwest

AveXis Announces Pricing of Public Offering of Common Stock - Jan. 17, 2018

The offering is expected to close on or about January 19, 2018, subject to customary closing conditions.

January 17, 2018
·
3 min read
Business

Biogennix Reports Record Growth for 2017; Expands Executive Management Team

The company closed the year with 47% growth, the broadest increase the company has experienced in its history.

January 17, 2018
·
3 min read
Business

Dentsply Sirona Names Cardinal Health Exec as New Leader

Mr. Casey succeeds Mark A. Thierer, who served as Interim Chief Executive Officer since September 28, 2017.

January 17, 2018
·
4 min read